Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bower

Showing results (201-210 of 252) with videos related to

Pageof 26
Sort By:
Leukemia & Lymphoma|December 5, 2012
A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphomaShireen Kassam, Mark Bower, Siow Ming Lee, et al.
AIDS (London, England)|February 9, 2016
Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?David C Boettiger, Caroline A Sabin, Andrew Grulich, et al.
AIDS (London, England)|March 7, 2013
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UKEmilio Letang, James J Lewis, Mark Bower, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 1, 2019
Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor TherapyDavid J Pinato, Heather Urus, Thomas Newsom-Davis, et al.
AIDS (London, England)|January 15, 2014
HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART eraRita Coutinho, Alessia D Pria, Shreyans Gandhi, et al.
Cancer Research|June 11, 2020
Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus ProductionSilvia Gramolelli, Endrit Elbasani, Krista Tuohinto, et al.
American Journal of Hematology|February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter studyJorge J Castillo, Brady E Beltran, Michele Bibas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyLeah Shepherd, Lene Ryom, Matthew Law, et al.
Scientific Reports|June 24, 2018
PROX1 is a transcriptional regulator of MMP14Silvia Gramolelli, Jianpin Cheng, Ines Martinez-Corral, et al.
British Journal of Cancer|August 22, 2022
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancerAlessio Cortellini, Juan Aguilar-Company, Ramon Salazar, et al.
Pageof 26

Showing results (201-210 of 252) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|December 5, 2012
A retrospective, multi-center analysis of treatment intensification for human immunodeficiency virus-positive patients with high-risk diffuse large B-cell lymphomaShireen Kassam, Mark Bower, Siow Ming Lee, et al.
AIDS (London, England)|February 9, 2016
Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?David C Boettiger, Caroline A Sabin, Andrew Grulich, et al.
AIDS (London, England)|March 7, 2013
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UKEmilio Letang, James J Lewis, Mark Bower, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 1, 2019
Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor TherapyDavid J Pinato, Heather Urus, Thomas Newsom-Davis, et al.
AIDS (London, England)|January 15, 2014
HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART eraRita Coutinho, Alessia D Pria, Shreyans Gandhi, et al.
Cancer Research|June 11, 2020
Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus ProductionSilvia Gramolelli, Endrit Elbasani, Krista Tuohinto, et al.
American Journal of Hematology|February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter studyJorge J Castillo, Brady E Beltran, Michele Bibas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyLeah Shepherd, Lene Ryom, Matthew Law, et al.
Scientific Reports|June 24, 2018
PROX1 is a transcriptional regulator of MMP14Silvia Gramolelli, Jianpin Cheng, Ines Martinez-Corral, et al.
British Journal of Cancer|August 22, 2022
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancerAlessio Cortellini, Juan Aguilar-Company, Ramon Salazar, et al.
Pageof 26